Micron Biomedical, Inc. is a clinical-stage biopharmaceutical company on a rapid path to bring to market drugs and vaccines that are formulated into a proprietary patch technology that simplifies and improves the way actives are delivered, stored, and distributed. This technology is designed to increase patient access to drugs and vaccines that would otherwise require expert injection and to improve safety and efficacy by skin targeting.
News – Baker & Eastlack Ventures
BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific
Microneedle Flu Vaccine Market Size & Share Analysis - Industry
3D microstructures by Nanoscribe for various life science applications
CADD Admin Set, 114, 1.2 micron Filter
Micron Biomedical, Inc.
Cadd 55 Extention Set with 0.2 Micron Filter
Toldya Microneedle patch technology for Gates' Mark of the Beast
Technology - Micron Biomedical
Micron Biomedical Inc. Atlanta, GA, US Startup
Jeff Daskal, CPA - Micron Biomedical, Inc.